Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery
NCT ID: NCT02085551
Last Updated: 2020-06-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2014-03-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Indigo System in Acute Lower Limb Malperfusion
NCT03386370
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
NCT06747117
Post Market Surveillance to Evaluate the Efficacy and Safety of the INDIGO Aspiration System in Japan
NCT06446024
Acute Limb Ischaemia (ALI) Management With 'Indigo' Mechanical Aspiration System
NCT03295539
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System
NCT04144959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mechanical thrombectomy by the Indigo System
Mechanical Thrombectomy by the Indigo System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mechanical Thrombectomy by the Indigo System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment with components of the Penumbra and/or Indigo System.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Penumbra Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Saxon, MD
Role: PRINCIPAL_INVESTIGATOR
Tri-City Medical Center, San Diego, CA
Corey Teigen, MD
Role: PRINCIPAL_INVESTIGATOR
Sanford Medical Center Fargo, ND
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tri-City Medical Center
San Diego, California, United States
Baptist Health South Florida
Miami, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
Carolinas Medical Center
Charlotte, North Carolina, United States
Sanford Medical Center
Fargo, North Dakota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLP 7051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.